PDS Biotechnology Corp Quarterly Interest Expense in USD from Q3 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
PDS Biotechnology Corp quarterly/annual Interest Expense history and growth rate from Q3 2014 to Q1 2024.
  • PDS Biotechnology Corp Interest Expense for the quarter ending March 31, 2024 was $1.17M, a 21.5% increase year-over-year.
  • PDS Biotechnology Corp Interest Expense for the twelve months ending March 31, 2024 was $4.41M, a 93.3% increase year-over-year.
  • PDS Biotechnology Corp annual Interest Expense for 2023 was $4.21M, a 219% increase from 2022.
  • PDS Biotechnology Corp annual Interest Expense for 2022 was $1.32M.
  • PDS Biotechnology Corp annual Interest Expense for 2021 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $4.41M $1.17M +$208K +21.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $4.21M $1.17M +$256K +27.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $3.95M $1.07M +$672K +169% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.28M $995K +$995K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $2.28M $967K +$967K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.32M $919K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $397K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2020 $0 $0 -$33K -100% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-18
Q3 2020 $33K $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $33K $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $33K $0 -$606 -100% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $33.6K $33K +$32.1K +3603% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-18
Q3 2019 $1.5K $0 -$942 -100% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $2.44K $0 -$804 -100% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 $3.24K $606 -$353 -36.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $3.6K $890 -$587K -99.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 $591K $942 -$591K -99.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $1.18M $804 -$524K -99.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.71M $959 -$474K -99.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $2.18M $588K +$102K +20.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-21
Q3 2017 $2.08M $592K +$217K +57.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 $1.86M $525K +$363K +225% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $1.5M $475K +$294K +163% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 $1.2M $486K +$285K +141% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $919K $375K +$162K +76.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-01
Q2 2016 $757K $161K -$50.6K -23.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $807K $181K -$9.3K -4.89% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $816K $201K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $213K +$165K +344% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-01
Q2 2015 $212K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 $190K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q3 2014 $48K Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.